Medical Breakthrough For Recurrent Melanoma Patients

Melanoma is the most serious form of skin cancer, with more than 75,000 people diagnosed each year. Imlygic®, a new oncolytic viral therapy recently approved by the Food & Drug Administration,  helps to fight skin cancer in patients with melanoma recurrence after initial surgery.

Read more about advancements in the treatment of melanoma in the following article:

New Medication Giving Hope to Melanoma Patients